We know that researching sources of information can be difficult and time-consuming. We have taken the time to cite 50 of the most notable articles on Fenbendazole, and other Benzimidazole compounds. We hope you will take the time to study the literature. There are enough articles here to keep you busy for quite some time. For questions or discussion consider joining a Fenbendazole community support group HERE. 80,000+ people are communicating daily about fenbendazole.
1) Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways. https://www.nature.com/articles/s41598-018-30158-6
2) Unexpected Antitumorigenic Effect of Fenbendazole when Combined with Supplementary Vitamins. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687140/
3) Fenbendazole as a Potential Anticancer Drug.
http://ar.iiarjournals.org/content/33/2/355.full
4) The Anthelmintic Drug Mebendazole Induces Mitotic Arrest and Apoptosis by Depolymerizing Tubulin in Non-Small Cell Lung Cancer.
https://mct.aacrjournals.org/content/1/13/1201.long
5) Pilot study of albendazole in patients with advanced malignancy. Effect on serum tumor markers/high incidence of neutropenia.
https://www.ncbi.nlm.nih.gov/pubmed/11474247
6) Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and a xenograft model of peritoneal carcinomatosis.
https://www.ncbi.nlm.nih.gov/pubmed/15565325
7) Benzimidazole as Novel Therapy for Hormone-Refractory Metastatic Prostate Cancer.
https://apps.dtic.mil/dtic/tr/fulltext/u2/a545657.pdf
8) Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells.
https://www.ncbi.nlm.nih.gov/pubmed/18667591
9) Phase I clinical trial to determine the maximum tolerated dose of oral albendazole in patients with advanced cancer.
https://link.springer.com/article/10.1007%2Fs00280-009-1157-8
10) Repurposing Drugs in Oncology (ReDO) — mebendazole as an anti-cancer agent.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096024/
11) Anthelmintic Flubendazole and Its Potential Use in Anticancer Therapy.
https://pdfs.semanticscholar.org/2b47/0bf133be75b36c09ebc8b17e70cea85fd9af.pdf
12) Chronic myelogenous leukemia in a great horned owl (Bubo virginianus)
https://www.ncbi.nlm.nih.gov/pubmed/19530405
13) Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells. Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells – PMC (nih.gov)
14) Fenbendazole as a Potential Anticancer Drug. Fenbendazole as a Potential Anticancer Drug – PMC (nih.gov)
15) Anthelmintics as Potential Anti-Cancer Drugs? Anthelmintics as Potential Anti-Cancer Drugs? – PMC (nih.gov)
Recent Posts
- Unlocking the Synergy: Fenbendazole and Cannabis in Cancer and Chronic Illness Treatment
- Fenbendazole Market 2024: Emerging Trends, Key Players, and Future Growth Prospects
- Promoting Integrity in Alternative Cancer Treatments: Advocating for Purity and Transparency in Medicinal Therapies
- The Unheralded Pioneer: Steve Beddingfield’s Journey with Fenbendazole
- Fenbendazole: Common Parasitic Drug OR Unexpected Weapon Against Cancer?